Insiders · Profile

Taveras Arthur

Chief Scientific Officer at X4 Pharmaceuticals. Filing since 13 Feb 2023. CIK 0001830901

Company

Date

Role

Action

Amount

Of holding

XFOR X4 Pharmaceuticals, Inc

7 Oct 2024

Chief Scientific Officer

Sold at will

76,920

$43.31K

16.5%

XFOR X4 Pharmaceuticals, Inc

11 Mar 2024

Chief Scientific Officer

Sold at will

14,235

$12.55K

5.7%

XFOR X4 Pharmaceuticals, Inc

12 Feb 2024

Chief Scientific Officer

Sold at will

787

$792.67

0.3%

XFOR X4 Pharmaceuticals, Inc

1 Nov 2023

Chief Scientific Officer

Sold on a plan

67,695

$49.42K

21.4%

XFOR X4 Pharmaceuticals, Inc

10 Mar 2023

Chief Scientific Officer

Sold, plan not stated

16,806

$14.12K

16.3%

XFOR X4 Pharmaceuticals, Inc

13 Feb 2023

Chief Scientific Officer

Sold, plan not stated

928

$863.04

0.9%

6 decisions on file.